Most bought healthcare stocks in Q3 2017
See which Healthcare stocks institutional investors increased the most in Q3 2017, measured as net growth in reported share positions from Q2 2017 into Q3 2017. Notable additions at the top of this list include TEVA PHARMACEUTICAL-SP ADR (TEVA), IDEXX LABORATORIES INC (IDXX), ELI LILLY & CO (LLY), GILEAD SCIENCES INC (GILD). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 21,518,081 | $369.10M | 1 | 0 | 1 | 0 | 4 |
| IDXX | IDEXX LABORATORIES INC | 14,284,778 | $895.45M | 0 | 2 | 0 | 0 | 3 |
| LLY | ELI LILLY & CO | 12,228,616 | $1.10B | 1 | 2 | 2 | 0 | 6 |
| GILD | GILEAD SCIENCES INC | 8,794,375 | $1.05B | 2 | 4 | 4 | 3 | 12 |
| HOLX | HOLOGIC INC | 6,786,692 | $230.60M | 1 | 1 | 2 | 0 | 4 |
| XRAY | DENTSPLY SIRONA INC | 2,937,033 | $161.63M | 0 | 2 | 1 | 0 | 3 |
| CAH | CARDINAL HEALTH INC | 1,817,619 | $18.62M | 0 | 6 | 0 | 0 | 7 |
| CERS | CERUS CORP | 1,482,391 | $4.43M | 0 | 2 | 0 | 0 | 2 |
| EXEL | EXELIXIS INC | 1,359,550 | $31.97M | 0 | 1 | 0 | 0 | 1 |
| VRTX | VERTEX PHARMACEUTICALS INC | 1,346,320 | $205.20M | 0 | 1 | 0 | 0 | 1 |
| EW | EDWARDS LIFESCIENCES CORP | 1,307,903 | $92.24M | 0 | 2 | 2 | 0 | 4 |
| CTLT | CATALENT INC | 1,190,200 | $52.34M | 0 | 1 | 1 | 0 | 2 |
| AMRN | AMARIN CORP PLC -ADR | 1,058,336 | $2.49M | 0 | 1 | 0 | 0 | 1 |
| MOH | MOLINA HEALTHCARE INC | 1,042,475 | $70.71M | 0 | 2 | 0 | 0 | 2 |
| CORT | CORCEPT THERAPEUTICS INC | 986,355 | $39.16M | 0 | 1 | 0 | 0 | 1 |
| WAT | WATERS CORP | 892,704 | $129.69M | 0 | 3 | 1 | 0 | 4 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | 827,872 | $111.14M | 0 | 2 | 0 | 0 | 2 |
| TMO | THERMO FISHER SCIENTIFIC INC | 800,431 | $246.75M | 1 | 4 | 6 | 1 | 15 |
| CVS | CVS HEALTH CORP | 778,061 | $77.47M | 0 | 4 | 4 | 1 | 9 |
| COR | CENCORA INC | 742,538 | -$618.00K | 1 | 1 | 1 | 0 | 3 |
| ALGN | ALIGN TECHNOLOGY INC | 714,725 | $352.73M | 1 | 2 | 3 | 0 | 6 |
| UNH | UNITEDHEALTH GROUP INC | 686,001 | $311.44M | 0 | 6 | 9 | 1 | 16 |
| GMED | GLOBUS MEDICAL INC - A | 608,900 | $17.86M | 0 | 1 | 0 | 0 | 1 |
| VCYT | VERACYTE INC | 518,677 | $4.78M | 0 | 2 | 0 | 0 | 2 |
| MCK | MCKESSON CORP | 467,578 | -$47.49M | 1 | 4 | 2 | 0 | 8 |
| PINC | PREMIER INC-CLASS A | 459,179 | $10.72M | 0 | 2 | 0 | 0 | 3 |
| RDNT | RADNET INC | 453,304 | $8.00M | 0 | 1 | 0 | 0 | 1 |
| UTHR | UNITED THERAPEUTICS CORP | 435,400 | $40.52M | 0 | 1 | 0 | 0 | 1 |
| A | AGILENT TECHNOLOGIES INC | 415,118 | $51.22M | 1 | 0 | 1 | 0 | 3 |
| AKBA | AKEBIA THERAPEUTICS INC | 395,600 | $13.21M | 0 | 1 | 0 | 0 | 1 |
| SYK | STRYKER CORP | 385,923 | $73.23M | 0 | 3 | 2 | 0 | 5 |
| PCRX | PACIRA BIOSCIENCES INC | 356,700 | $13.21M | 0 | 1 | 0 | 0 | 1 |
| EBS | EMERGENT BIOSOLUTIONS INC | 332,200 | $18.80M | 0 | 1 | 0 | 0 | 1 |
| INVA | INNOVIVA INC | 304,650 | $7.84M | 1 | 0 | 1 | 0 | 2 |
| CCRN | CROSS COUNTRY HEALTHCARE INC | 292,508 | $4.52M | 0 | 1 | 0 | 0 | 1 |
| MCRB | SERES THERAPEUTICS INC | 280,331 | $10.30M | 0 | 2 | 0 | 0 | 2 |
| VERU | VERU INC | 274,000 | $726.00K | 1 | 0 | 0 | 0 | 1 |
| DGX | QUEST DIAGNOSTICS INC | 253,483 | $13.23M | 0 | 1 | 1 | 0 | 2 |
| VCEL | VERICEL CORP | 250,192 | $1.50M | 1 | 0 | 0 | 0 | 1 |
| PRGO | Perrigo Company PLC | 242,532 | $66.46M | 0 | 2 | 1 | 1 | 3 |
| GLYC | GLYCOMIMETICS INC | 235,500 | $3.33M | 0 | 1 | 0 | 0 | 1 |
| AMGN | AMGEN INC | 227,752 | $100.73M | 1 | 2 | 7 | 0 | 11 |
| HQY | HEALTHEQUITY INC | 227,400 | $11.60M | 0 | 1 | 0 | 0 | 2 |
| PETS | PETMED EXPRESS INC | 221,215 | -$4.94M | 0 | 1 | 0 | 0 | 1 |
| IART | INTEGRA LIFESCIENCES HOLDING | 201,200 | $10.12M | 0 | 1 | 0 | 0 | 1 |
| RVTY | REVVITY INC | 196,600 | $13.56M | 1 | 0 | 0 | 0 | 1 |
| AZTA | AZENTA INC | 191,000 | $9.19M | 0 | 1 | 0 | 0 | 1 |
| PAHC | PHIBRO ANIMAL HEALTH CORP-A | 184,316 | $6.83M | 0 | 1 | 0 | 0 | 1 |
| VREX | VAREX IMAGING CORP | 183,163 | $6.31M | 1 | 1 | 1 | 1 | 4 |
| NTLA | INTELLIA THERAPEUTICS INC | 178,468 | $6.15M | 0 | 1 | 0 | 1 | 1 |
Frequently asked questions about Most bought healthcare stocks in Q3 2017
What are the most bought Healthcare stocks in Q3 2017?
The most bought healthcare stocks in Q3 2017 are those with the largest increase in reported share counts across institutional investors compared to Q2 2017, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q3 2017?
Among filers in this sector, net additions were largest in companies such as TEVA PHARMACEUTICAL-SP ADR (TEVA), IDEXX LABORATORIES INC (IDXX), ELI LILLY & CO (LLY), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q2 2017).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.